LifeMD ROE 2011-2024 | LFMD
Current and historical return on equity (ROE) values for LifeMD (LFMD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| LifeMD ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-06-30 | $-0.03B | $-0.00B | 1866.67% |
| 2024-03-31 | $-0.03B | $0.00B | 800.00% |
| 2023-12-31 | $-0.03B | $0.01B | 454.55% |
| 2023-09-30 | $-0.03B | $-0.01B | 377.14% |
| 2023-06-30 | $-0.03B | $-0.01B | 647.62% |
| 2023-03-31 | $-0.04B | $-0.01B | 4000.00% |
| 2022-12-31 | $-0.05B | $-0.01B | -1031.58% |
| 2022-09-30 | $-0.06B | $0.00B | -423.08% |
| 2022-06-30 | $-0.06B | $0.01B | -717.65% |
| 2022-03-31 | $-0.06B | $0.02B | -1347.37% |
| 2021-12-31 | $-0.06B | $0.03B | -12400.00% |
| 2021-09-30 | $-0.08B | $-0.02B | 1216.00% |
| 2021-06-30 | $-0.09B | $-0.01B | 1911.11% |
| 2021-03-31 | $-0.07B | $-0.00B | 1920.00% |
| 2020-12-31 | $-0.06B | $-0.00B | 1377.78% |
| 2020-09-30 | $-0.03B | $-0.01B | 666.67% |
| 2020-06-30 | $-0.01B | $-0.01B | 254.55% |
| 2020-03-31 | $-0.01B | $-0.00B | 285.71% |
| 2019-12-31 | $-0.00B | $-0.00B | 533.33% |
| 2019-09-30 | $-0.00B | $-0.00B | 1200.00% |
| 2019-06-30 | $-0.00B | $-0.00B | -1200.00% |
| 2019-03-31 | $-0.00B | $0.00B | -400.00% |
| 2018-12-31 | $-0.00B | $0.00B | -100.00% |
| 2018-09-30 | $-0.00B | $0.00B | -100.00% |
| 2018-06-30 | $-0.00B | $0.00B | -100.00% |
| 2018-03-31 | $0.00B | $0.00B | 133.33% |
| 2017-12-31 | $-0.00B | $0.00B | -400.00% |
| 2017-09-30 | $-0.00B | $0.00B | inf% |
| 2017-06-30 | $-0.00B | $0.00B | 400.00% |
| 2017-03-31 | $-0.00B | $-0.00B | 800.00% |
| 2016-12-31 | $-0.00B | $0.00B | inf% |
| 2016-09-30 | $0.00B | $0.00B | nan% |
| 2016-06-30 | $0.00B | $0.00B | nan% |
| 2016-03-31 | $0.00B | $0.00B | nan% |
| 2015-12-31 | $0.00B | $0.00B | nan% |
| 2015-09-30 | $0.00B | $0.00B | nan% |
| 2015-06-30 | $0.00B | $0.00B | nan% |
| 2015-03-31 | $0.00B | $0.00B | nan% |
| 2014-12-31 | $0.00B | $0.00B | nan% |
| 2014-09-30 | $0.00B | $0.00B | nan% |
| 2014-06-30 | $0.00B | $0.00B | nan% |
| 2014-03-31 | $0.00B | $0.00B | nan% |
| 2013-12-31 | $0.00B | $0.00B | nan% |
| 2013-09-30 | $0.00B | $0.00B | nan% |
| 2013-06-30 | $0.00B | $0.00B | nan% |
| 2013-03-31 | $0.00B | $0.00B | nan% |
| 2012-12-31 | $0.00B | $0.00B | nan% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.185B | $0.153B |
| LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $98.630B | 12.24 |
| Cencora (COR) | United States | $46.202B | 17.66 |
| DiDi Global (DIDIY) | China | $23.330B | 0.00 |
| ICON (ICLR) | Ireland | $18.188B | 16.34 |
| Avantor (AVTR) | United States | $15.249B | 22.89 |
| Natera (NTRA) | United States | $14.554B | 0.00 |
| Revvity (RVTY) | United States | $14.348B | 25.13 |
| Viatris (VTRS) | United States | $13.654B | 4.16 |
| BioMerieux (BMXMF) | France | $13.361B | 0.00 |
| Solventum (SOLV) | United States | $12.641B | 0.00 |
| CochLear (CHEOY) | Australia | $12.413B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.264B | 28.92 |
| Charles River Laboratories (CRL) | United States | $9.403B | 17.77 |
| Sonic Healthcare (SKHHY) | Australia | $8.777B | 0.00 |
| HealthEquity (HQY) | United States | $7.691B | 41.74 |
| Doximity (DOCS) | United States | $7.659B | 48.53 |
| Bausch + Lomb (BLCO) | Canada | $7.204B | 31.00 |
| PACS (PACS) | United States | $6.415B | 0.00 |
| Life Times (LTH) | United States | $4.688B | 32.21 |
| Organon (OGN) | United States | $4.418B | 4.49 |
| Sotera Health (SHC) | United States | $4.359B | 21.99 |
| Surgery Partners (SGRY) | United States | $3.746B | 41.51 |
| BrightSpring Health Services (BTSG) | United States | $2.658B | 0.00 |
| Concentras Parent (CON) | United States | $2.647B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.533B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.356B | 88.71 |
| Alignment Healthcare (ALHC) | United States | $2.112B | 0.00 |
| Premier (PINC) | United States | $1.980B | 8.90 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.922B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.584B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.508B | 7.57 |
| Teladoc Health (TDOC) | United States | $1.467B | 0.00 |
| Progyny (PGNY) | United States | $1.395B | 24.52 |
| Establishment Labs Holdings (ESTA) | $1.247B | 0.00 | |
| CareDx (CDNA) | United States | $1.181B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.066B | 11.60 |
| Agilon Health (AGL) | United States | $1.062B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.936B | 24.50 |
| Embecta (EMBC) | United States | $0.802B | 5.35 |
| InnovAge Holding (INNV) | United States | $0.768B | 0.00 |
| SBC Medicals (SBC) | United States | $0.737B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.461B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.429B | 0.00 |
| Enhabit (EHAB) | United States | $0.354B | 30.61 |
| DocGo (DCGO) | United States | $0.350B | 13.15 |
| Biodesix (BDSX) | United States | $0.238B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.232B | 0.00 |
| ModivCare (MODV) | United States | $0.205B | 6.52 |
| Beauty Health (SKIN) | United States | $0.205B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.184B | 0.00 |
| MultiPlan (MPLN) | United States | $0.156B | 0.00 |
| Nutex Health (NUTX) | United States | $0.123B | 0.00 |
| So-Young (SY) | China | $0.104B | 25.12 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.051B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.69 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.035B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| Oncology Institute (TOI) | United States | $0.025B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |